E-TAG Priority claimed from 11/03/2022; Application No. : 97/307,414 ;United States of America
Goods or services claimed
Diagnostic reagents for medicinal use; Reagent kits for diagnostic medical purposes comprising labeled antibodies or label for antibodies, namely, biological reagents used to detect and measure biological analytes for use in the fields of biological and diagnostic testing for medical and/or veterinary use THIS IS CONDITION OF REGISTRATION THAT BOTH/ALL LABELS SHALL BE USED TOGETHER..
Similar marks in class 5, same issue
- EMRUXIV Priority claimed from 20/05/2022; Application No. : 97421223 ;United States of America similar · Principia Biopharma Inc.
- REBALANCE Priority claimed from 05/01/2022; Application No. : 97204174 ;United States of America similar · Rebalance Health, Inc.
- Priority claimed from 08/02/2023; Application No. : 97786648 ;United States of America similar · [International Registration No. : 1758004]
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for E-TAG Priority claimed from 11/03/2022; Application No. : 97/307,414 ;United States of America
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.